Photoselective vaporization of the prostate: Evaluation of conflicts of interest and industrial sponsorship stratified by favorability of the study outcome
Marian S. Wettstein(University of Zurich), Thomas Hermanns(University of Cologne), Jaime O. Herrera‐Cáceres, Antje Neumann(Krankenhaus Nordwest), Tullio Sulser(University Hospital of Zurich), G.S. Kulkarni, Cédric Poyet(University of Zurich), Dixon Woon, Clinsy Pazhepurackel
Cited by 0
Related Papers
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers
|Proceedings of the National Academy of Sciences|2000|427
Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients
|Proceedings of the National Academy of Sciences|2006|217
Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients
|Proceedings of the National Academy of Sciences|2012|199
Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial
|British Journal of Cancer|2007|185